TargetRx Awarded Patent for Innovative Method of Predicting Prescribing Behavior.
HORSHAM, Pa. -- TargetRx, a pharmaceutical sales and marketing effectiveness company, today announced that it has been awarded a patent by the United States Patent and Trademark Office (U.S. Patent #7,080,027), titled "Method and System for Analyzing the Effectiveness of Marketing Strategies." Demonstrating the company's continued commitment to innovation, this newly patented method of predicting prescribing behavior allows TargetRx to provide highly actionable insights that help pharmaceutical companies improve sales and marketing performance.
TargetRx has revolutionized the industry's approach to evaluating sales and marketing effectiveness by focusing on how well a company influences physicians to prescribe its products for appropriate patients. Over the past six years, TargetRx has built a unique and powerful database of 200 million responses to questions collected from more than 70,000 U.S. physicians. The information that TargetRx derives from this database allows pharmaceutical companies to understand specific opportunities to grow market share and to make the best decisions regarding their sales and marketing initiatives. More specifically, with its patented analysis, TargetRx predicts prescribing behavior, uncovers the drivers of that behavior, and clearly identifies the actions that affect prescribing most effectively.
"This patent reinforces the unique power of our approach and our continued dedication to improving our clients' performance by providing valuable and actionable insight in a way that no other company can," said Mike Luby, CEO of TargetRx. "Our 'Method for Analyzing the Effectiveness of Marketing Strategies' is sound and proven to deliver high quality sales and marketing insights that help pharmaceutical companies make better-informed, strategic decisions that will ultimately increase physician prescribing."
TargetRx is a pharmaceutical sales and marketing effectiveness company that provides actionable insight to pharmaceutical companies to help them effectively sell and market their products and improve their financial performance. TargetRx has developed a highly predictive database of physician attitudes that it uses in combination with its patented analytic methods to provide pharmaceutical companies with powerful "leading indicators" of how their sales and marketing initiatives will affect physician prescribing. TargetRx benchmarks performance, identifies immediate improvement opportunities and predicts future performance for its clients. TargetRx works with the majority of the top 30 pharmaceutical companies in the U.S. For further information, visit www.targetrx.com.
|Printer friendly Cite/link Email Feedback|
|Date:||Oct 2, 2006|
|Previous Article:||Webcast Alert: Gastar Exploration, Ltd. Announces Its 2006 OGIS West Investment Symposium Webcast.|
|Next Article:||Working Wiper Blades Increase Visibility, Decrease Accidents.|